Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT06977620
Eligibility Criteria:
Inclusion Criteria:
Women who had a history of BCRS with upper limb lymphedema. • Age range of 40-60 years.
• The body mass index (BMI) is less than 30 Kg/m2.
• Consciousness and ability to communicate orally or in writing.
• Treatment by unilateral mastectomy with lymph node dissection.
• No obvious abnormal spine morphology or postural abnormalities visible to the naked eye.
• All participants had moderate lymphedema according to the lymphedema severity assessment.
Exclusion Criteria:
Patients with metastases. • Differences between lower limb length.
• Having acute or chronic vestibular, neurological, and orthopedic diseases.
• Surgery related to spine causing limitation of motion.
• Women with psychiatric disorders, reconstructive surgery.
• Bilateral mastectomy. Diagnosis with a neurological, skeletal, or rheumatic disorder or other disease that seriously affects body posture.
• History of bodily injury such as a spinal, shoulder, or neck injury, resulting in permanent alteration of the normal body posture prior to the unilateral mastectomy.
• Failure to complete follow-up for any reason over the course of the study.
• Peripheral polyneuropathy, cognitive dysfunction.
• Patients taking medication that affects body balance.
• Severe arthritis or orthopedic conditions in their lower extremity
• Poor conditioning, acute pain in any reason,
• Neurological disorders including visual problems.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
40 Years
Maximum Age:
60 Years
Study:
NCT06977620
Study Brief:
Protocol Section:
NCT06977620